Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide/Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related ILD
NCT03770663Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Feb 2021
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus + Wuzhi capsule in antisynthetase syndrome (ASSD), interstitial lung disease (ILD), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
antisynthetase syndrome (ASSD)interstitial lung disease (ILD)
Beyond the preview
Go deeper on NCT03770663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03770663.